Anekant Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2017.
2017 Delhi, Delhi, India Active
Last Updated:
Access Report
About Anekant Pharmaceuticals Private Limited

Anekant Pharmaceuticals Private Limited, a active private limited company, was established on 06 February 2017 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U36100DL2017PTC311457. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.55 M.

Formerly known as Seramejor Technologies Private Limited, Invent Pharma Agencies Private Limited. It upholds a compliant status. Its leadership includes Jai Krishan Aggarwal (Director), Pankaj Jain (Additional Director), Motilal Chawla (Director). Past directors included Anju Rastogi, Amit Rastogi, Jai Krishan Aggarwal. It holds ₹1.10 Cr open charges and no settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at B-399 Nirman Vihar, Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U36100DL2017PTC311457

  • Registration Number

    311457

  • Incorporation Date

    06 February 2017

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹0.55 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 0.55 M
  • Company Age 9 Year, 3 Months
  • Last Filing with ROC 31 Mar 2021
  • Open Charges ₹ 1.10 Cr
  • Revenue Growth **** 54.32%
  • Profit Growth **** 7.89%
  • Ebitda **** -0.13%
  • Net Worth 97.65%
  • Total Assets **** 185.99%
Company report

Anekant Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Anekant Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Anekant Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Jai Krishan Aggarwal Director 31 Jul 2020 Current
Pankaj Jain Additional Director 10 Oct 2021 Current
Motilal Chawla Director 01 May 2023 Current
Ashish Kumar Singh Director 31 Jul 2020 Current
Anil Kumar Director 01 May 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 15 Dec 2021 Past
Pramod Abcsdd Additional Director 02 May 2023 Past
Pramod Abcsdd Director 25 Aug 2021 Past
Pramod Abcsdd Director 10 Oct 2021 Past
Pramod Abcsdd Additional Director 30 Sep 2018 Past
Pramod Abcsdd Director 11 Nov 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Anekant Pharmaceuticals.

Anekant Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 54.32% increase. The company also saw a slight improvement in profitability, with a 7.89% increase in profit. The company's net worth Soared by an impressive increase of 97.65%.

Anekant Pharmaceuticals revenue growth over time
Anekant Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 54.32%
*******
*******
*******
*******
Revenue from Operations
*******
 54.35%
*******
*******
*******
*******
Total Assets
*******
 185.99%
*******
*******
*******
*******
Profit or Loss
*******
 7.89%
*******
*******
*******
*******
Net Worth
*******
 97.65%
*******
*******
*******
*******
EBITDA
*******
 -0.13%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Anekant Pharmaceuticals?

In 2021, Anekant Pharmaceuticals had a promoter holding of 76.67% and a public holding of 23.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹11,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 1.10 Cr
Latest Charge Details
Date Lender Amount Status
03 Feb 2021 Others ₹1.10 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Anekant Pharmaceuticals?

Unlock and access historical data on people associated with Anekant Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Anekant Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anekant Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Anekant Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Motilal Chawla was appointed as a Director was appointed as a Director on 01 May 2023 & has been associated with this company since 3 years 24 days . was documented.

  • Director Appointment

    Anil Kumar was appointed as a Director was appointed as a Director on 01 May 2023 & has been associated with this company since 3 years 24 days . was recorded as a recent event.

  • Annual General Meeting

    The activity Anekant Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.

  • Director Appointment

    Pankaj Jain was appointed as a Additional Director was appointed as a Additional Director on 10 Oct 2021 & has been associated with this company since 4 years 7 months . was recorded as a recent event.

  • Balance Sheet

    Anekant Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 11.00 M with Charge ID 100413520 was registered on 03 Feb 2021. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Anekant Pharmaceuticals Private Limited?

The CIN of Anekant Pharmaceuticals Private Limited is U36100DL2017PTC311457.

Where is Anekant Pharmaceuticals Private Limited headquartered?

Anekant Pharmaceuticals Private Limited is headquartered at B-399 Nirman Vihar, Delhi, Delhi, 110092.

When was Anekant Pharmaceuticals Private Limited incorporated?

Anekant Pharmaceuticals Private Limited was incorporated on 06 February 2017.

Who are the current directors of Anekant Pharmaceuticals Private Limited?

The current directors of Anekant Pharmaceuticals Private Limited are

What is the primary industry of Anekant Pharmaceuticals Private Limited?

The primary industry of Anekant Pharmaceuticals Private Limited is Trade.

Is Anekant Pharmaceuticals Private Limited a listed company?

Anekant Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Anekant Pharmaceuticals Private Limited?

The authorized capital of Anekant Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹0.55 M.

What is the compliance status of Anekant Pharmaceuticals Private Limited?

The compliance status of Anekant Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available